Abstract
According to data collected in the UK for weeks 34-52 in 2021 (excluding week 51 which was not covered) and in weeks 1-12 of 2022 — a period of 28 weeks during which the genetic “vaccines” from Pfizer, Moderna, and AstraZeneca were being pressed upon the public — deaths reported to Public Health England (PHE) from their hospital “trusts” were being tabulated in a series of vaccine surveillance reports. Each source for the data analyzed here covered a four-week period. Deaths were reported to PHE from under age 18, progressing in increments of 10 years to 80 or older. In addition to deaths, the UK National Immunization Management System also recorded the date of a positive COVID-19 test result, and dates of any vaccinations. To obtain non-overlapping records, the 7 surveillance reports relied on here appeared in weeks 38, 42, 47, and 51 in 2021 and 4, 9, and 13 in 2022. Assuming that dying was not reported more than once for any individual, and, that dates of positive COVID-19 tests and COVID-19 vaccinations were reasonably reliable, we believe there is no good reason to doubt the data or the analyses we are reporting. During the 28 weeks we are referring to, we found an almost perfect correlation between the total deaths within 60 days of a positive COVID-19 test, across the various age groups (a) from any cause whatever and (b) deaths after the persons who died had received one, two, or three doses of at least one of the COVID-19 vaccines. We simply collated the data from the various UK Health Security Agency vaccine surveillance reports to discover a correlation of 0.99881, coefficient of determination at 0.99762, between (a) and (b). The shots account for almost exactly 100% of the variance in death-from-all-causes in the UK data set.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Vaccine Theory, Practice, and Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.